BERBERIAN LANCE (CIK 1102900) reported 10 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-22). Recent activity: Buy PRVA (8,463 shares), Buy PRVA (7,668 shares), Buy LH (3,325 shares), Sell LH (1,353 shares), Buy LH (323 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-22 | Privia Health Group, Inc. (PRVA) | Director | Buy | 8,463 | $0 |
| 2025-07-17 | Privia Health Group, Inc. (PRVA) | Director | Buy | 7,668 | $0 |
| 2025-03-31 | LABCORP HOLDINGS INC. (LH) | EVP, Special Advisor, Strategy | Buy | 3,325 | $0 |
| 2025-03-31 | LABCORP HOLDINGS INC. (LH) | EVP, Special Advisor, Strategy | Sell | 1,353 | $313,450 |
| 2025-02-13 | LABCORP HOLDINGS INC. (LH) | EVP, Special Advisor, Strategy | Buy | 323 | $0 |
| 2025-02-13 | LABCORP HOLDINGS INC. (LH) | EVP, Special Advisor, Strategy | Sell | 86 | $21,082 |
| 2025-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Special Advisor, Strategy | Buy | 356 | $0 |
| 2025-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Special Advisor, Strategy | Sell | 94 | $23,288 |
| 2025-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Special Advisor, Strategy | Buy | 354 | $0 |
| 2025-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Special Advisor, Strategy | Sell | 94 | $23,149 |
Source: SEC Form 4 filings · as of 2026-05-22